CD133 and DNA-PK upregulate P-glycoprotein via activation of the AKT–NFκB pathway in multidrug-resistant glioblastoma cells invitro (Xi et al., 2016), which is in accordance with our findings. This evidence concerns the gene NFKB1 and glioblastoma.